Business Wire

OH-PROCTER-&-GAMBLE

Share
Procter & Gamble Hosts Global Olympians Justine & Chloe Dufour-Lapointe, Michelle Kwan, Elana Meyers Taylor and Katarzyna Bachleda-Curuś to Discuss Gender Bias

As part of the Olympic Winter Games PyeongChang 2018, Procter & Gamble (NYSE: PG), a Worldwide Olympic Partner, today hosted a panel discussion on gender equality. As part of “Love Over Bias,” the latest installment of P&G’s award-winning “Thank You, Mom” campaign, a panel of decorated female Olympians discussed their own journeys to the global stage. The discussion included the role of their moms, mentorship and support from other women, as well as their hopes for what the current global movement for gender equality will mean for future generations of female athletes.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180213005989/en/

With opening remarks from Anita DeFrantz, Olympic medalist, the first female Vice President of the IOC Executive Board and a tireless advocate for gender equality in sport, the panel was comprised of:

  • Michelle Kwan – Olympic medalist and world champion and the most decorated U.S. figure skater who now serves as a global advocate for her sport and women in business
  • Elana Meyers Taylor – 2012 & 2014 Olympic medalist who was one of the first women to pilot a mixed gender, four-man bobsled and has defied stereotypes in her sport
  • Katarzyna Bachleda-Curuś – Polish speed skating record holder, two-time Olympic medalist competing in her fifth Olympic Winter Games and proud mom of two daughters
  • Justine & Chloe Dufour-Lapointe – Canadian mogul skiers who both medaled at the Olympic Winter Games Sochi 2014. Justine won a silver medal in PyeongChang.

“It’s an exciting time to be a female athlete,” said Elana Meyers Taylor. “There’s this incredible change we’re seeing across all facets of global culture—politics, entertainment, business and of course sport. I’m extremely fortunate that I had fantastic female mentors, including my mom, who helped me overcome any adversity I faced as a female competing in mixed gender bobsled events. I always believed that if I couldn’t do something, my mom would be the one to tell me, and she never did, so I didn’t set limitations for myself and I hope that attitude will inspire other women to define their own potential.”

“I’m proud to partner with P&G today to support the Love Over Bias campaign and participate in a discussion about gender equality,” said Justine Dufour-Lapointe. “I wouldn’t be here without the support and mentorship from other women, including my sisters and my strong and inspiring mom. Together, we can help shape the future for female athletes.”

The discussion also included a screening of P&G Korea’s “Thank You, Mom” video with decorated speed skater Sangwha Lee as well as P&G’s celebrated “Love Over Bias” film, which celebrates a mom’s role as her child’s first and greatest advocate, the one who sees her child’s potential regardless of how others see them. The hope is that this film will help bring people together to talk openly about bias, its role in limiting human potential and the need to see beyond the things that divide us to the common things that can bring us together.

“At P&G, we aspire to create a better world for everyone -- a world free from bias, with equal representation, equal voices and equal opportunity,” said Phil Duncan, Global Design Officer. “The campaign is part of a company-wide effort to spark conversations about important matters, such as gender bias. This has been a longstanding journey for P&G, which includes other campaigns such as Ariel Share the Load , Always Like a Girl , SK-II Marriage Market Takeover , and Secret’s Ladies’ Room Stress Test .”

Share #LoveOverBias and go to www.LoveOverBias.com to view the film and learn more these and other athletes.

About P&G’s Olympic Games Program:

Around the world P&G brands including Always®, Gillette®, Pantene®, Head & Shoulders®, Tide®, Bounty® and Downy® will be executing Olympic Games campaigns through a variety of media channels and in-store. P&G brands are committed to giving moms the best, each and every day. Not just moms of Olympians, but all moms, all around the world. As a Worldwide Olympic Partner, when P&G brands like Tide, Gillette and Pampers partner with athletes on their Olympic Games journey, P&G also recognizes the mom who supported them every step of the way.

About P&G

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

Contact:

Procter & Gamble
Ivanette Bonilla, 513–725–5131
E-mail: bonilla.i@pg.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release

Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release

IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye